butalbital, acetaminophen, caffeine (68788-8137)

Drug Facts

Product Profile

Brand Name butalbital, acetaminophen, caffeine

Generic Name butalbital, acetaminophen, and caffeine

Labeler preferred pharmaceuticals inc.

Dosage Form TABLET

Routes

ORAL

Active Ingredients

acetaminophen 325 mg/1, butalbital 50 mg/1, caffeine 40 mg/1

Manufacturer

Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8137

Product ID 68788-8137_86030039-f5fa-41de-accf-c59a7493f2b5

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA209587

DEA Schedule ciii

Listing Expiration 2026-12-31

Marketing Start 2022-02-11

Pharmacologic Class

Established (EPC)

barbiturate [epc] central nervous system stimulant [epc] methylxanthine [epc]

Chemical Structure

barbiturates [cs] xanthines [cs]

Physiologic Effect

central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888137

Hyphenated Format 68788-8137

Supplemental Identifiers

RxCUI

238154

UNII

362O9ITL9D KHS0AZ4JVK 3G6A5W338E

NUI

N0000175693 M0002177 N0000175739 N0000175729 N0000175790 M0023046

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name butalbital, acetaminophen, caffeine (source: ndc)

Generic Name butalbital, acetaminophen, and caffeine (source: ndc)

Application Number ANDA209587 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

325 mg/1
50 mg/1
40 mg/1

source: ndc

Packaging

20 TABLET in 1 BOTTLE (68788-8137-2)
30 TABLET in 1 BOTTLE (68788-8137-3)

source: ndc

Packages (2)

68788-8137-2 20 TABLET in 1 BOTTLE (68788-8137-2) 68788-8137-3 30 TABLET in 1 BOTTLE (68788-8137-3)

Ingredients (3)

acetaminophen (325 mg/1) butalbital (50 mg/1) caffeine (40 mg/1)

Linked Drug Pages (1)

Butalbital, Acetaminophen, Caffeine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "86030039-f5fa-41de-accf-c59a7493f2b5", "openfda": {"nui": ["N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "KHS0AZ4JVK", "3G6A5W338E"], "rxcui": ["238154"], "spl_set_id": ["b121190e-db2a-43bb-a57d-b6683a9e2059"], "pharm_class_cs": ["Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8137-2)", "package_ndc": "68788-8137-2", "marketing_start_date": "20220211"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8137-3)", "package_ndc": "68788-8137-3", "marketing_start_date": "20220211"}], "brand_name": "Butalbital, Acetaminophen, Caffeine", "product_id": "68788-8137_86030039-f5fa-41de-accf-c59a7493f2b5", "dosage_form": "TABLET", "pharm_class": ["Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "68788-8137", "dea_schedule": "CIII", "generic_name": "Butalbital, Acetaminophen, and Caffeine", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Butalbital, Acetaminophen, Caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}], "application_number": "ANDA209587", "marketing_category": "ANDA", "marketing_start_date": "20220211", "listing_expiration_date": "20261231"}